Related Experiment Video
Updated: Jun 5, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Resistant hypertension despite nine different antihypertensive drugs?]
Philip M Muck1, Jürgen Steinhoff, Hendrik Lehnert
1Medizinische Klinik I, Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Germany.
Treatment-resistant hypertension can stem from patients not adhering to their medication regimen. Addressing non-compliance through education and supervised intake can effectively manage blood pressure and reduce medication needs.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Treatment-resistant hypertension (TRH) is a prevalent issue in outpatient settings, frequently leading to hospitalizations.
- Key contributors to TRH include unidentified secondary hypertension, hypertensive nephrosclerosis, and patient non-compliance.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure V: Medical Management
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics